Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Preti

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry|December 14, 2007
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Delia Preti, et al.
Scientific Reports|April 7, 2017
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligandsSalvatore Pacifico, Alfonso Carotenuto, Diego Brancaccio, et al.
Journal of Medicinal Chemistry|June 23, 2006
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Giovanna Pavani, et al.
Journal of Medicinal Chemistry|November 22, 2023
Spiropiperidine-Based Oligomycin-Analog Ligands To Counteract the Ischemia-Reperfusion Injury in a Renal Cell ModelGiulia Turrin, Ettore Lo Cascio, Noah Giacon, et al.
Journal of Medicinal Chemistry|March 21, 2003
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry|February 20, 2007
N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptorPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|January 29, 2013
Design, synthesis, and pharmacological properties of new heteroarylpyridine/heteroarylpyrimidine derivatives as CB(2) cannabinoid receptor partial agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Giulia Saponaro, et al.
Pharmacological Research|February 23, 2019
The acyl-glucuronide metabolite of ibuprofen has analgesic and anti-inflammatory effects via the TRPA1 channelFrancesco De Logu, Simone Li Puma, Lorenzo Landini, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
[3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptorsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2022
Identification of small-molecule urea derivatives as PTPC modulators targeting the c subunit of F<sub>1</sub>/F<sub>o</sub>-ATP synthaseAnna Fantinati, Giampaolo Morciano, Giulia Turrin, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry|December 14, 2007
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Delia Preti, et al.
Scientific Reports|April 7, 2017
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligandsSalvatore Pacifico, Alfonso Carotenuto, Diego Brancaccio, et al.
Journal of Medicinal Chemistry|June 23, 2006
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Giovanna Pavani, et al.
Journal of Medicinal Chemistry|November 22, 2023
Spiropiperidine-Based Oligomycin-Analog Ligands To Counteract the Ischemia-Reperfusion Injury in a Renal Cell ModelGiulia Turrin, Ettore Lo Cascio, Noah Giacon, et al.
Journal of Medicinal Chemistry|March 21, 2003
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry|February 20, 2007
N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptorPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|January 29, 2013
Design, synthesis, and pharmacological properties of new heteroarylpyridine/heteroarylpyrimidine derivatives as CB(2) cannabinoid receptor partial agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Giulia Saponaro, et al.
Pharmacological Research|February 23, 2019
The acyl-glucuronide metabolite of ibuprofen has analgesic and anti-inflammatory effects via the TRPA1 channelFrancesco De Logu, Simone Li Puma, Lorenzo Landini, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
[3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptorsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2022
Identification of small-molecule urea derivatives as PTPC modulators targeting the c subunit of F<sub>1</sub>/F<sub>o</sub>-ATP synthaseAnna Fantinati, Giampaolo Morciano, Giulia Turrin, et al.
Pageof 10